secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0001628280-25-032627
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals secures $40M equity line with Lincoln Park Capital
---------------------------------------------------------------------

- Company may sell up to $40M of common stock to Lincoln Park over 24 months.
- Purchase price set at 97% of the lower of lowest or 3-day-average closing price.
- Regular purchases capped at 30k–60k shares per day based on stock price thresholds.
- Issued 137,099 commitment shares to Lincoln Park as a fee for entering the agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000162828025032627/0001628280-25-032627-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000162828025032627/xfor-20250623.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-032627

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer